Clinical Trials Directory

Trials / Completed

CompletedNCT02335567

Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms

Status
Completed
Phase
Study type
Observational
Enrollment
162 (actual)
Sponsor
Michigan State University · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Accepted

Summary

To compare two competing newly designed 3D sequences for black blood carotid plaque imaging techniques with the industry standard 2D sequnce for black blood.

Detailed description

To utilize a 3D sequence instead of the usual 2D commonly standard industry sequence that is supplied by the various manufacturers. Patients with greater than 50% stenosis that are 3T compatible are imaged using the two sequences to compare which sequences better visualize the plaque and it's characteristics The purpose is to validate the ability of the new 3D sequence to detect and measure any plaque hemorrhage as well as to identify region sof Type 1 hemorrhage.

Conditions

Interventions

TypeNameDescription
OTHERthere is no intervention

Timeline

Start date
2012-06-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2015-01-09
Last updated
2016-09-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02335567. Inclusion in this directory is not an endorsement.

Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms (NCT02335567) · Clinical Trials Directory